References
1. Abbott Press Release: Abbott's Panbio™ Rapid Antigen Test Now Has a CE Mark for Use on Children; First Rapid Antigen Test with Performance Data on Children.
2. Panbio COVID-19 Ag Rapid Test Device Instructions For Use. 2021.
3. Abbott's Panbio™ Rapid Antigen Self-Test Receives CE Mark, Increasing Access to Fast, Reliable COVID-19 Testing in the United Kingdom.
4. Abbott Press Release: Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results.
5. Internal clinical data held on file.
6. Moore N, et al. Evaluation of the Alere™ i Influenza A & B 2 Assay. 2018 ASM Clinical Virology Symposium, West Palm Beach, FL. Poster.
7. Chartrand C, et al, Accuracy of Rapid Influenza Diagnostic Tests A Meta-analysis. Ann Intern Med. 2012;156(7);500-511.
8. Chartrand C, et al. Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta-analysis. J Clin Microbiol. 2015;53(12):3738-3749.
9. ID NOW RSV Product Insert.
10. ID NOW™ Strep A 2 clinical trial data, held on file.
11. ID NOW™ Strep A 2 Product Insert.
12. Cohen JF, et al. Rapid antigen detection test for group A streptococcus in children with pharyngitis (Review). Cochrane Database of Systematic Reviews. 2016, Issue 7.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
FOLLOW ABBOTT